Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib versus prednisolone versus combination therapy for withdrawal headache in medication overuse headache
IRCT20181014041334N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in medication overuse headache (MOH) comparing Celecoxib group, Prednisolone group and Prednisolone plus celecoxib group (3 arms). Primary endpoint: Headache severity. Started Nov 2018; status: completed.
02
Drugs
celecoxibprednisolone
03
Conditions
medication overuse headache (MOH)
Beyond the preview
Go deeper on IRCT20181014041334N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181014041334N1.